RBC Capital analyst Frank Morgan lowered the firm’s price target on Universal Health to $140 from $152 and keeps a Sector Perform rating on the shares. The company reported “solid” Q3 results and the firm was pleased to see strong volume momentum in the acute segment, with meaningful declines in premium labor costs, the analyst tells investors in a research note. While RTC volumes in the behavioral segment are beginning to reflect Medicaid redetermination, the administrative coverage losses should be transitory, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on UHS: